Stay updated on Remdesivir Efficacy in Mild-Moderate COVID-19 Clinical Trial

Sign up to get notified when there's something new on the Remdesivir Efficacy in Mild-Moderate COVID-19 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Remdesivir Efficacy in Mild-Moderate COVID-19 Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    7 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details related to a Phase 3 randomized, double-blind, placebo-controlled multicenter study evaluating the efficacy and safety of Remdesivir in hospitalized adult patients with mild and moderate COVID-19.
    Difference
    0.1%
    Check dated 2024-06-06T14:40:35.000Z thumbnail image
  7. Check
    22 days ago
    Change Detected
    Summary
    The webpage has updated the 'Participation Criteria' section to provide detailed eligibility criteria for study participants, including age, confirmed COVID-19 diagnosis, and specific health conditions, replacing the previous placeholder text.
    Difference
    17%
    Check dated 2024-05-22T21:11:41.000Z thumbnail image
  8. Check
    44 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:26:52.000Z thumbnail image

Stay in the know with updates to Remdesivir Efficacy in Mild-Moderate COVID-19 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Remdesivir Efficacy in Mild-Moderate COVID-19 Clinical Trial page.